Style | Citing Format |
---|---|
MLA | Elhusseiny AM, et al.. "Current and Emerging Therapies for Limbal Stem Cell Deficiency." Stem Cells Translational Medicine, vol. 11, no. 3, 2022, pp. 259-268. |
APA | Elhusseiny AM, Soleimani M, Eleiwa TK, Elsheikh RH, Frank CR, Naderan M, Yazdanpanah G, Rosenblatt MI, Djalilian AR (2022). Current and Emerging Therapies for Limbal Stem Cell Deficiency. Stem Cells Translational Medicine, 11(3), 259-268. |
Chicago | Elhusseiny AM, Soleimani M, Eleiwa TK, Elsheikh RH, Frank CR, Naderan M, Yazdanpanah G, Rosenblatt MI, Djalilian AR. "Current and Emerging Therapies for Limbal Stem Cell Deficiency." Stem Cells Translational Medicine 11, no. 3 (2022): 259-268. |
Harvard | Elhusseiny AM et al. (2022) 'Current and Emerging Therapies for Limbal Stem Cell Deficiency', Stem Cells Translational Medicine, 11(3), pp. 259-268. |
Vancouver | Elhusseiny AM, Soleimani M, Eleiwa TK, Elsheikh RH, Frank CR, Naderan M, et al.. Current and Emerging Therapies for Limbal Stem Cell Deficiency. Stem Cells Translational Medicine. 2022;11(3):259-268. |
BibTex | @article{ author = {Elhusseiny AM and Soleimani M and Eleiwa TK and Elsheikh RH and Frank CR and Naderan M and Yazdanpanah G and Rosenblatt MI and Djalilian AR}, title = {Current and Emerging Therapies for Limbal Stem Cell Deficiency}, journal = {Stem Cells Translational Medicine}, volume = {11}, number = {3}, pages = {259-268}, year = {2022} } |
RIS | TY - JOUR AU - Elhusseiny AM AU - Soleimani M AU - Eleiwa TK AU - Elsheikh RH AU - Frank CR AU - Naderan M AU - Yazdanpanah G AU - Rosenblatt MI AU - Djalilian AR TI - Current and Emerging Therapies for Limbal Stem Cell Deficiency JO - Stem Cells Translational Medicine VL - 11 IS - 3 SP - 259 EP - 268 PY - 2022 ER - |